Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
Long COVID in autoimmune rheumatic diseases
Y Fedorchenko, O Zimba - Rheumatology International, 2023 - Springer
Abstract Consequences of Corona Virus Disease-19 (COVID-19) in patients with rheumatic
diseases (RDs) are clinically diverse. SARS-CoV-2 infection has been associated with …
diseases (RDs) are clinically diverse. SARS-CoV-2 infection has been associated with …
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 …
Background We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
and severe COVID-19 outcomes among individuals with immune-mediated inflammatory …
Trends in delirium and new antipsychotic and benzodiazepine use among hospitalized older adults before and after the onset of the COVID-19 pandemic
C Reppas-Rindlisbacher, A Boblitz… - JAMA Network …, 2023 - jamanetwork.com
Importance The COVID-19 pandemic caused large disruptions to health care for
hospitalized older adults. The incidence and management of delirium may have been …
hospitalized older adults. The incidence and management of delirium may have been …
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
C Ferri, L Gragnani, V Raimondo, M Visentini… - Journal of …, 2022 - Elsevier
Autoimmune systemic diseases (ASD) show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed at evaluating the …
vaccines. Our prospective observational multicenter study aimed at evaluating the …
Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
A Barmada, LF Handfield… - European Journal of …, 2024 - Wiley Online Library
In COVID‐19, hyperinflammatory and dysregulated immune responses contribute to
severity. Patients with pre‐existing autoimmune conditions can therefore be at increased risk …
severity. Patients with pre‐existing autoimmune conditions can therefore be at increased risk …
[HTML][HTML] Интерстициальные заболевания легких при ревматоидном артрите: мультидисциплинарная проблема ревматологии и пульмонологии
ЕЛ Насонов, ЛП Ананьева… - Научно-практическая …, 2022 - cyberleninka.ru
Ревматоидный артрит (РА)-иммуновоспалительное ревматическое заболевание
(ИВРЗ), характеризующееся хроническим эрозивным артритом и системным …
(ИВРЗ), характеризующееся хроническим эрозивным артритом и системным …
Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
GE Fragoulis, VK Bournia, PP Sfikakis - Clinical Rheumatology, 2022 - Springer
COVID-19 has been associated with increased morbidity and mortality, globally. Whether
COVID-19-related mortality is increased in patients with systemic rheumatic diseases …
COVID-19-related mortality is increased in patients with systemic rheumatic diseases …
The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
G Striani, A Hoxha, M Lorenzin, G Cozzi… - Frontiers in …, 2023 - frontiersin.org
Objectives To investigate the effects of SARS-CoV-2 infection, as well as short-(within 48
hours) and long-term (within 30 days) adverse events (AEs) of SARS-CoV-2 vaccines …
hours) and long-term (within 30 days) adverse events (AEs) of SARS-CoV-2 vaccines …
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory …
Q Wei, PJ Mease, M Chiorean, L Iles-Shih… - The Lancet Digital …, 2024 - thelancet.com
Background In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19
outcomes are incompletely understood and vary considerably depending on the patient …
outcomes are incompletely understood and vary considerably depending on the patient …